Viewing Study NCT04948034


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-31 @ 11:16 AM
Study NCT ID: NCT04948034
Status: UNKNOWN
Last Update Posted: 2021-08-27
First Post: 2021-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module